Zobrazeno 1 - 10 of 1 046 pro vyhledávání: '"Spiriti MA"'
1
Report
Loss of CDKN1B induces an age-related clonal hematopoietic disorder via Notch2 activity dysregulation.
Autor: Segatto I; Division of Molecular Oncology, Centro di Riferimento Oncologico di Aviano (CRO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), National Cancer Institute, Aviano (PN), Italy., Rampioni Vinciguerra GL; Division of Molecular Oncology, Centro di Riferimento Oncologico di Aviano (CRO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), National Cancer Institute, Aviano (PN), Italy.; Department of Clinical and Molecular Medicine, University of Rome 'La Sapienza', Santo Andrea Hospital, Rome, Italy., Pellarin I; Division of Molecular Oncology, Centro di Riferimento Oncologico di Aviano (CRO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), National Cancer Institute, Aviano (PN), Italy., Dall'Acqua A; Division of Molecular Oncology, Centro di Riferimento Oncologico di Aviano (CRO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), National Cancer Institute, Aviano (PN), Italy., Berton S; Division of Molecular Oncology, Centro di Riferimento Oncologico di Aviano (CRO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), National Cancer Institute, Aviano (PN), Italy., Citron F; Division of Molecular Oncology, Centro di Riferimento Oncologico di Aviano (CRO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), National Cancer Institute, Aviano (PN), Italy., D'Andrea S; Division of Molecular Oncology, Centro di Riferimento Oncologico di Aviano (CRO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), National Cancer Institute, Aviano (PN), Italy., Mungo G; Division of Molecular Oncology, Centro di Riferimento Oncologico di Aviano (CRO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), National Cancer Institute, Aviano (PN), Italy., Viotto D; Division of Molecular Oncology, Centro di Riferimento Oncologico di Aviano (CRO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), National Cancer Institute, Aviano (PN), Italy., Musco L; Division of Molecular Oncology, Centro di Riferimento Oncologico di Aviano (CRO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), National Cancer Institute, Aviano (PN), Italy., Di Napoli A; Department of Clinical and Molecular Medicine, University of Rome 'La Sapienza', Santo Andrea Hospital, Rome, Italy., Aloe Spiriti MA; Department of Clinical and Molecular Medicine, University of Rome 'La Sapienza', Santo Andrea Hospital, Rome, Italy., Canzonieri V; Division of Pathology, Centro di Riferimento Oncologico di Aviano (CRO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), National Cancer Institute, Aviano (PN), Italy., Gattei V; Division of Clinical and Experimental Onco-Hematology, Centro di Riferimento Oncologico di Aviano (CRO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), National Cancer Institute, Aviano (PN), Italy., Vecchione A; Department of Clinical and Molecular Medicine, University of Rome 'La Sapienza', Santo Andrea Hospital, Rome, Italy., Belletti B; Division of Molecular Oncology, Centro di Riferimento Oncologico di Aviano (CRO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), National Cancer Institute, Aviano (PN), Italy., Baldassarre G; Division of Molecular Oncology, Centro di Riferimento Oncologico di Aviano (CRO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), National Cancer Institute, Aviano (PN), Italy.
Publikováno v: Cancer communications (London, England) [Cancer Commun (Lond)] 2023 Jul; Vol. 43 (7), pp. 844-849. Date of Electronic Publication: 2023 Jun 19.
Zobrazit plný text záznamu
2
Akademický článek
Myelodysplastic Syndromes with Isolated 20q Deletion: A New Clinical-Biological Entity?
Autor: Campagna A; Hematology, Sant'Andrea Hospital, Sapienza University, 00185 Rome, Italy., De Benedittis D; Hematology, Policlinico Umberto I, Sapienza University, 00185 Rome, Italy., Fianchi L; Hematology, Policlinico Gemelli, University of Sacred Heart, 00168 Rome, Italy., Scalzulli E; Hematology, Policlinico Umberto I, Sapienza University, 00185 Rome, Italy., Rizzo L; Hematology, Policlinico Umberto I, Sapienza University, 00185 Rome, Italy., Niscola P; Hematology, Sant'Eugenio Hospital, 00144 Rome, Italy., Piccioni AL; Hematology, San Giovanni Hospital, 00184 Rome, Italy., Di Veroli A; Hematology, Belcolle Hospital, 01100 Viterbo, Italy., Mancini S; Hematology, San Camillo Hospital, 00152 Rome, Italy., Villivà N; Hematology, ASL RM1, 00193 Rome, Italy., Martini T; AOU Ospedali Riuniti, Università Politecnica Marche, 60126 Ancona, Italy., Mohamed S; Hematology, Policlinico Umberto I, Sapienza University, 00185 Rome, Italy., Carmosino I; Hematology, Policlinico Umberto I, Sapienza University, 00185 Rome, Italy., Criscuolo M; Hematology, Policlinico Gemelli, University of Sacred Heart, 00168 Rome, Italy., Fenu S; Hematology, San Giovanni Hospital, 00184 Rome, Italy., Aloe Spiriti MA; Hematology, Sant'Andrea Hospital, Sapienza University, 00185 Rome, Italy., Buccisano F; Hematology, University Tor Vergata, 00133 Rome, Italy., Mancini M; Hematology, Policlinico Umberto I, Sapienza University, 00185 Rome, Italy., Tafuri A; Hematology, Sant'Andrea Hospital, Sapienza University, 00185 Rome, Italy., Breccia M; Hematology, Policlinico Umberto I, Sapienza University, 00185 Rome, Italy., Poloni A; AOU Ospedali Riuniti, Università Politecnica Marche, 60126 Ancona, Italy., Latagliata R; Hematology, Belcolle Hospital, 01100 Viterbo, Italy.
Publikováno v: Journal of clinical medicine [J Clin Med] 2022 May 05; Vol. 11 (9). Date of Electronic Publication: 2022 May 05.
Zobrazit plný text záznamu
3
Akademický článek
Pulmonary infections in patients with myelodysplastic syndromes receiving frontline azacytidine treatment.
Autor: Latagliata R; Hematology, Dipartimento Medicina Traslazionale e di Precisione, AOU Policlinico Umberto I, Sapienza University of Rome, Rome, Italy., Niscola P; Hematology, Sant'Eugenio Hospital, Rome, Italy., Fianchi L; Hematology, Univerità Cattolica del Sacro Cuore, Rome, Italy., Aloe Spiriti MA; Hematology, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy., Maurillo L; Hematology, University Tor Vergata, Rome, Italy., Carmosino I; Hematology, Dipartimento Medicina Traslazionale e di Precisione, AOU Policlinico Umberto I, Sapienza University of Rome, Rome, Italy., Cesini L; Hematology, Dipartimento Medicina Traslazionale e di Precisione, AOU Policlinico Umberto I, Sapienza University of Rome, Rome, Italy., Sarlo C; Hematology, University Campus Biomedico, Rome, Italy., Piccioni A; Hematology, Azienda Ospedaliera S. Giovanni-Addolorata, Rome, Italy., Campagna A; Hematology, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy., De Luca ML; Hematology, Dipartimento Medicina Traslazionale e di Precisione, AOU Policlinico Umberto I, Sapienza University of Rome, Rome, Italy., De Benedittis D; Hematology, Dipartimento Medicina Traslazionale e di Precisione, AOU Policlinico Umberto I, Sapienza University of Rome, Rome, Italy., Mancini M; Hematology, Dipartimento Medicina Traslazionale e di Precisione, AOU Policlinico Umberto I, Sapienza University of Rome, Rome, Italy., Breccia M; Hematology, Dipartimento Medicina Traslazionale e di Precisione, AOU Policlinico Umberto I, Sapienza University of Rome, Rome, Italy., Criscuolo M; Hematology, Univerità Cattolica del Sacro Cuore, Rome, Italy., Buccisano F; Hematology, University Tor Vergata, Rome, Italy., Voso MT; Hematology, University Tor Vergata, Rome, Italy., Avvisati G; Hematology, University Campus Biomedico, Rome, Italy., Tafuri A; Hematology, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy., De Fabritiis P; Hematology, Sant'Eugenio Hospital, Rome, Italy., Foà R; Hematology, Dipartimento Medicina Traslazionale e di Precisione, AOU Policlinico Umberto I, Sapienza University of Rome, Rome, Italy., Girmenia C; Hematology, Dipartimento Medicina Traslazionale e di Precisione, AOU Policlinico Umberto I, Sapienza University of Rome, Rome, Italy.
Publikováno v: Hematological oncology [Hematol Oncol] 2020 Apr; Vol. 38 (2), pp. 189-196. Date of Electronic Publication: 2020 Jan 23.
Zobrazit plný text záznamu
4
Akademický článek
A multidisciplinary expert opinion on CINV and RINV, unmet needs and practical real-life approaches.
Autor: Bossi P; Medical Oncology, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health University of Brescia, ASST-Spedali Civili, Brescia, Italy., Airoldi M; Oncology Departement, Città della Salute e della Scienza Hospital of Turin, Turin, Italy., Aloe Spiriti MA; Department of Clinical and Molecular Medicine, Azienda Universitaria Ospedaliera Sant'Andrea, 'Sapienza' University of Rome, Rome, Italy., Antonuzzo A; Medical Oncology Unit 1 SSN, Pisa University Hospital, Pisa, Italy., Bonciarelli G; Medical Oncology Department, Monselice, Italy., Campagna A; Department of Hematology, Azienda Universitaria Ospedaliera Sant'Andrea, 'Sapienza' University of Rome, Rome, Italy., Cassano A; Division of Medical Oncology, Catholic University of the Sacred Heart, Rome, Italy., Murialdo R; Department of Internal Medicine and Medical Specialties (Di.M.I.), University of Genoa and IRCCS AOU San Martino-IST, Genoa, Italy., Musio D; Department of Radiotherapy, Policlinico Umberto I 'Sapienza' University of Rome, Rome, Italy., Silvano G; Radiation Oncology Unit, San Giuseppe Moscati Hospital, Taranto, Italy.
Publikováno v: Expert opinion on drug safety [Expert Opin Drug Saf] 2020 Feb; Vol. 19 (2), pp. 187-204. Date of Electronic Publication: 2020 Feb 06.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje